Author:
Burslem George M.,Smith Blake E.,Lai Ashton C.,Jaime-Figueroa Saul,McQuaid Daniel C.,Bondeson Daniel P.,Toure Momar,Dong Hanqing,Qian Yimin,Wang Jing,Crew Andrew P.,Hines John,Crews Craig M.
Funder
Leukemia and Lymphoma Society Career Development
NCI
NIH
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry
Reference64 articles.
1. Met/hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for hrs phosphorylation;Abella;Mol. Cell. Biol.,2005
2. ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells;Anido;Clin. Cancer Res.,2003
3. Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion;Asaoka;Biochem. Biophys. Res. Commun.,2010
4. Met, metastasis, motility and more;Birchmeier;Nat. Rev. Mol. Cell Biol.,2003
5. Catalytic in vivo protein knockdown by small-molecule PROTACs;Bondeson;Nat. Chem. Biol.,2015
Cited by
472 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献